Business
Cannabis Companies Expanding Global Footprint; The Greater Cannabis Company Inc. (OTC:GCAN), Aphria, Canopy Growth and AgraFlora Organics
Cannabis Companies Expanding Global Footprint; The Greater Cannabis Company Inc. (OTC:GCAN), Aphria, Canopy Growth and AgraFlora Organics.
About this update from Greater Cannabis Co Inc.
[{"type":"text","content":"\nPOINT ROBERTS, Wash. and DELTA, British Columbia, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Investorideas.com, a leading investor news resource covering cannabis stocks releases a snapshot looking at the global expansion of the cannabis industry and the companies looking at new international markets as regulations change.\n As new international markets being to open, both cannabis giants as well as smaller cannabis technology companies are now making the necessary preparations to enter this international space. The Greater Cannabis Company, Inc. (OTC:GCAN), recently announced that it has entered into a letter of intent with iCAN Cannabis to expand distribution of its eluting patch platform into key global markets. The eluting patch platform is an innovative delivery system which uses a patented mucoadhesive and multilayered orally dissolving thin film to deliver a precise dose of cannabinoids into the body through the buccal mucosa. Clinical studies, funded in part by the National Institutes of Health (NIH), have shown the delivery system’s capability in achieving higher bioavailability and desired results in the body using lower and controlled dosing when compared to other routes of administration. The agreement with iCAN will include commercial ready formulations to meet medical and recreational market demands. Distribution and marketing rights for iCAN will include Israel, Australia, South Africa, Netherlands, Mexico, Colombia, Panama, Germany, Austria, Switzerland, Malta, Macedonia and Portuguese territories. In their recent news release, Aitan Zacharin, CEO of Greater Cannabis said, “I am pleased to announce our partnership with iCAN. Saul is an industry leader who is at the forefront of everything tech in cannabis. His desire to partner with us is a testament to the strength of our technology and its capabilities. We are excited to establish this important partnership in the medical and adult-use cannabis industry. We are focused on transactions that will accelerate commercialization of our products and the iCAN deal does that globally. iCAN shares our enthusiasm for seeing healthier, standardized, pharmaceutical-grade and more cost-effective cannabis products introduced into the market. We look forward to working with iCan to bring our cutting-edge technology to consumers worldwide.” Similarly, in December of ...